User profiles for Gabriel Reina
 | Gabriel Reina PharmD PhDClinica Universidad de Navarra (Microbiology) Verified email at unav.es Cited by 1752 |
[HTML][HTML] The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind …
Background Ivermectin inhibits the replication of SARS-CoV-2 in vitro at concentrations not
readily achievable with currently approved doses. There is limited evidence to support its …
readily achievable with currently approved doses. There is limited evidence to support its …
Immunogenicity and crossreactivity of antibodies to the nucleocapsid protein of SARS-CoV-2: utility and limitations in seroprevalence and immunity studies
…, M Tortajada, F Carmona-Torre, G Reina… - Translational …, 2021 - Elsevier
COVID-19 patients elicit strong responses to the nucleocapsid (N) protein of SARS-CoV-2
but binding antibodies are also detected in prepandemic individuals, indicating potential …
but binding antibodies are also detected in prepandemic individuals, indicating potential …
Highly sensitive and specific multiplex antibody assays to quantify immunoglobulins M, A, and G against SARS-CoV-2 antigens
…, F Carmona-Torre, G Reina… - Journal of clinical …, 2021 - Am Soc Microbiol
Reliable serological tests are required to determine the prevalence of antibodies against
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and to characterize immunity …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and to characterize immunity …
[HTML][HTML] Orthohepevirus C infection as an emerging cause of acute hepatitis in Spain: First report in Europe
Background & Aim Hepatitis E virus (HEV) was considered the only member of the Hepeviridae
family with zoonotic potential. Nevertheless, this consideration has been reassessed …
family with zoonotic potential. Nevertheless, this consideration has been reassessed …
[HTML][HTML] Neutrophil extracellular traps, local IL-8 expression, and cytotoxic T-lymphocyte response in the lungs of patients with fatal COVID-19
…, M Fernández-Alonso, M Rodríguez-Mateos, G Reina… - Chest, 2022 - Elsevier
Background Excessive inflammation is pathogenic in the pneumonitis associated with
severe COVID-19. Neutrophils are among the most abundantly present leukocytes in the …
severe COVID-19. Neutrophils are among the most abundantly present leukocytes in the …
SARS-CoV-2 susceptibility and COVID-19 illness course and outcome in people with pre-existing neurodegenerative disorders: Systematic review with frequentist and …
Background People with neurodegenerative disease and mild cognitive impairment (MCI)
may have an elevated risk of acquiring severe acute respiratory syndrome coronavirus 2 (…
may have an elevated risk of acquiring severe acute respiratory syndrome coronavirus 2 (…
The slowdown of new infections by human retroviruses has reached a plateau in Spain
…, B Encinas, A Aguilera, G Reina… - Journal of medical …, 2023 - Wiley Online Library
The 2022 annual meeting of the HTLV & HIV‐2 Spanish Network was held in Madrid on
December 14. We summarize here the main information presented and discussed at the …
December 14. We summarize here the main information presented and discussed at the …
[HTML][HTML] Humoral and cellular immune response over 9 months of mRNA-1273, BNT162b2 and ChAdOx1 vaccination in a University Hospital in Spain
…, F Carmona-Torre, S Carlos, MM Sarasa, G Reina - Scientific Reports, 2022 - nature.com
Scarce data have been reported about cellular immunity and longevity for different COVID-19
vaccination schedules. We carried out a prospective study enrolling 709 healthcare …
vaccination schedules. We carried out a prospective study enrolling 709 healthcare …
[HTML][HTML] A predictive model for hospitalization and survival to COVID-19 in a retrospective population-based study
The development of tools that provide early triage of COVID-19 patients with minimal use of
diagnostic tests, based on easily accessible data, can be of vital importance in reducing …
diagnostic tests, based on easily accessible data, can be of vital importance in reducing …
[HTML][HTML] The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe …
…, JS Mota, JR Yuste, JR Azanza, M Fernández, G Reina… - Trials, 2020 - Springer
Objectives The primary objective is to determine the efficacy of a single dose of ivermectin,
administered to low risk, non-severe COVID-19 patients in the first 48 hours after symptom …
administered to low risk, non-severe COVID-19 patients in the first 48 hours after symptom …
